title: [Treatment strategy for stage I testicular germ cell tumor].
abstract: Most stage I testicular germ cell tumors are curable by orchiectomy alone. However, some tumors recur and require subsequent treatment. The point for the management of stage I testicular germ cell tumors is how to reduce the recurrence rate by appropriate adjuvant treatment with less adverse events. The strategy for stage I seminoma and stage I nonseminoma is different. The adjuvant treatment options include radiotherapy and 1-2 courses of carboplatin for seminoma and retroperitoneal lymph node dissection (RPLND) and 1-2 courses of bleomycin, etoposide and cisplatin chemotherapy for nonseminoma. This review discusses recent literature on adjuvant treatment and updates the consensus for the management of stage I testicular germ cell tumor.
authors: The Department of Urology, Osaka University Graduate School of Medicine, Osaka, Japan.
authors: Yasutomo
authors: Y
authors: Nakai
authors: Akira
authors: A
authors: Nagahara
authors: Motohide
authors: M
authors: Uemura
authors: Hitoshi
authors: H
authors: Takayama
authors: Norio
authors: N
authors: Nonomura
mesh_terms: D017024:Chemotherapy, Adjuvant; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009373:Neoplasms, Germ Cell and Embryonal / Q000628:therapy*; D013736:Testicular Neoplasms / Q000628:therapy*